If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
Design Innovations Contribute to Improved Deliverability MINNEAPOLIS–(HSMN NewsFeed)–Medtronic, Inc. (NYSE: MDT ), today began the international launch of the Driver Sprint RX Coronary Stent System, which received the CE (Conformité Europ&eacut…
Devices, Interventional Cardiology
Medtronic, Driver Sprint RX, Coronary Stent, Driver BMS
Posts from ‘March, 2009’
Medtronic Announces International Market Release of Driver Sprint RX Coronary Stent System
New Clinical Study Shows Masimo PVI(TM) Accurately Predicts Fluid Responsiveness in the ICU
First Study to Expand PVI Utility Beyond the OR Presented at the 29th International Symposium on Intensive Care and Emergency Medicine in Brussels IRVINE, Calif., March 31 (HSMN NewsFeed) — Masimo (Nasdaq: MASI ), the inventor of Pulse CO-Oximetry(TM…
Devices, Monitoring
Masimo, Masimo PVI
Mylan’s Matrix Receives First Tentative FDA Approval Under PEPFAR for Generic Truvada(R)
PITTSBURGH, March 30 (HSMN NewsFeed) — Mylan Inc. (Nasdaq: MYL ) today announced that Matrix Laboratories Limited, its India-based subsidiary in which it holds a 71.2% controlling interest, has received the first tentative approval from the U.S. Food an…
Biopharmaceuticals, Generics, FDA
Mylan, Matrix Laboratories Limited, PEPFAR, Gilead Sciences, Truvada
FDA Approves Abiomed’s New AB Portable Driver; Providing Patient Transport, Mobility and Ambulation without Compromising Performance
Quiet, Lightweight, Compact Driver Delivers Intuitive, Integrated Solution DANVERS, Mass.–(HSMN NewsFeed)–Abiomed, Inc. (NASDAQ: ABMD ), a major provider of heart recovery products designed to recover hearts and eliminate in-hospital deaths from hea…
Devices, FDA, Cardiology
Abiomed, AB Portable driver, Bi-Ventricular Assist Device, AB5000
St. Jude Pharma and GE Healthcare Announce Worldwide Market Launch of Wireless Integrated FFR Solution
UPPSALA, Sweden & WAUKESHA, Wis. & ST. PAUL, Minn.–(HSMN NewsFeed)–St. Jude Pharmaceutical, Inc. (NYSE:STJ ) and GE Healthcare today announced the worldwide commercial launch of the first fully integrated wireless solution for the measurement of Fractional Flow…
Devices, Interventional Cardiology
St. Jude Laboratory, GE Healthcare, Fractional Flow Reserve, PressureWire, Aeris
Nabriva Therapeutics Appoints Dr David Chiswell as Chief Executive Officer
VIENNA, Austria–(HSMN NewsFeed)–Nabriva Therapeutics, a biotechnology company focused on developing a new class of antibiotics for serious infections caused by resistant pathogens, has announced the appointment of Dr David Chiswell as its Chief Executive…
Biopharmaceuticals, Personnel
Nabriva Therapeutics
Sagent Pharmaceuticals Announces U.S. FDA Approval of Azithromycin for Injection
First product approval from Sagent and Strides Arcolab Joint Venture SCHAUMBURG, Ill., March 26 (HSMN NewsFeed) — Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced U.S. Food and Drug Administration (FDA)…
Biopharmaceuticals, FDA
Sagent Pharmaceuticals, Strides Arcolab, azithromycin
Physio-Control Receives FDA 510(k) Clearance for LIFEPAK 15 Monitor/Defibrillator
REDMOND, Wash.–(HSMN NewsFeed)–Physio-Control, Inc., a wholly owned subsidiary of Medtronic, Inc., (NYSE: MDT ) announced today it has received clearance from the U.S. Food and Drug Administration (FDA) to market the LIFEPAK 15 monitor/defibrillator with…
Devices, Monitoring, FDA
Medtronic, Physio-Control, LIFEPAK Fifteen
SenoRx Announces CE Mark to Commercialize Contura(tm) MLB in Europe
IRVINE, Calif., March 26, 2009 –(HSMN NewsFeed) — SenoRx (NasdaqGM:SENO ) today announced that it has received the right to apply the CE Mark to its Contura(tm) MLB short-term breast radiation balloon catheter. The multi-lumen radiation balloon delivers …
Devices, Oncology, Regulatory
SenoRx, Contura, radiation balloon catheter, lumpectomy, breast cancer
Atritech Completes $30 Million Financing
Company scheduled to announce PROTECT AF results on March 28th at ACC MINNEAPOLIS, March 26 (HSMN NewsFeed) — Atritech, Inc. a medical stage pathology device company, announced today that it has completed a $30 million round of financing. Thomas, McNe…
Devices, Cardiology, Venture Capital
Atritech, atrial fibrillation, cardiogenic stroke, cardioembolic stroke
